Clinical trial
A Study of the Effects of Desloratadine on Conjunctival Allergen…
NCT00311844 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00311844 |
|---|---|
| Title | A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209) |
| Official title | A Double-blind, Placebo-controlled, Crossover, Single-center Study to Evaluate the Anti-allergic and Anti-inflammatory Effects of Multiple Doses of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Conjunctivitis, Allergic |
| Intervention type | Drug |
| Interventions | desloratadine |
| Enrollment | 41 |
| Start date | Mar 1, 2005 |
| Primary completion | May 28, 2005 |
| Completion | May 28, 2005 |
| First posted | Apr 6, 2006 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: